Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder (MDD)

Clinical trial NCT02371980 · COMPLETED

Trial details

NCT number: NCT02371980
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Major Depressive Disorder

Start date: 2015-02-10
Primary completion: 2019-03-01
Enrollment: 1106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.